001_Delcath_CorporateLogo_Tagline.png
Delcath Systems, Inc. Announces Positive Preliminary Results from Phase 3 FOCUS Trial of HEPZATO in Patients with Metastatic Ocular Melanoma
March 31, 2021 07:30 ET | Delcath Systems, Inc.
Based on Preliminary Data, FOCUS Trial Achieves Prespecified Success Threshold Conference Call Today at 8:00am Eastern Time NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc....
Delcath Systems Schedules Conference Call to Report 2020 Fourth Quarter Financial Results
March 24, 2021 16:01 ET | Delcath Systems, Inc.
NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Participate at Upcoming Virtual Investor Conferences
March 08, 2021 09:00 ET | Delcath Systems, Inc.
NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Participate at Upcoming Virtual Investor Conferences
February 11, 2021 09:00 ET | Delcath Systems, Inc.
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems to Present at the H.C. Wainwright Virtual BioConnect Conference
January 11, 2021 10:56 ET | Delcath Systems, Inc.
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Completion of Underwritten Public Offering
December 11, 2020 10:31 ET | Delcath Systems, Inc.
NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Pricing of Public Offering of Common Stock
December 09, 2020 08:00 ET | Delcath Systems, Inc.
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Delcath Systems Announces Proposed Public Offering of Common Stock
December 08, 2020 16:01 ET | Delcath Systems, Inc.
NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver,...
Kevin Muir Joins Delcath Systems, Inc. as VP, Commercial Operations
December 07, 2020 07:30 ET | Delcath Systems, Inc.
NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...
Delcath Systems, Inc. Announces Third Quarter 2020 Results
November 11, 2020 08:00 ET | Delcath Systems, Inc.
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...